Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
8.37
-0.98 (-10.48%)
Mar 27, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $306.62 million as of March 27, 2026. Its market cap has increased by 330.15% in one year.
Market Cap
306.62M
Enterprise Value
585.95M
1-Year Change
330.15%
Ranking
Category
Stock Price
$8.37
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $306.62M, an increase of 562.03%. That is a compound annual growth rate of 31.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 306.62M | 34.11% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 320.68M |
| Neurogene | 316.94M |
| Avalo Therapeutics | 316.53M |
| PepGen | 312.40M |
| Rezolute | 310.58M |
| Opus Genetics | 309.50M |
| Greenwich LifeSciences | 309.37M |
| Puma Biotechnology | 309.33M |